Diagnosis, Staging, and Management for Gynecologic Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 1012
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, "Diagnosis, Staging, and Management for Gynecologic Oncology", provides an opportunity to present articles on clinical and translational research, retrospective analysis, or review types of articles in a wide range of aspects related to gynecological malignancies.
Significant progress in the field of cancer biology has made it possible to supplement traditional criteria for histopathological diagnosis with additional ones, e.g., those related to persistent HPV infections or the pool of molecular risk factors, which is growing along with research results, e.g., in endometrial and ovarian cancers. A comprehensive characterization of the individual patient's tumor is currently essential, primarily for the qualification for adjuvant treatment in operated patients and for the assessment of prognosis, which in turn may affect the scope of follow-up.
Modern imaging methods significantly facilitate the assessment of the advancement of reproductive organ cancer, qualification for treatment, e.g., surgery, radio(chemo)therapy or induction systemic treatment, and also provide important information of prognostic significance.
Updated cancer staging systems, e.g., the 2023 FIGO classification of endometrial cancer, allow for better definition of risk groups and thus facilitate the selection of the appropriate treatment method.
The treatment of malignant neoplasms of the reproductive organs is a very broad topic. We encourage you to submit articles on modern radiation therapy (including brachytherapy) both as a stand-alone treatment and combined with systemic treatment, as well as an adjuvant treatment, especially (but not only) for vulvar and vaginal cancers. The treatment of these rare cancers is often problematic in clinical practice. Examples of other topics worth presenting include HPV-independent cervical cancer (put aside a bit), unplanned breaks in radiotherapy and use of the L–Q model formula with changing radiation dose fractionation parameters, radioresistance, repeated irradiation with the intention of radical treatment, and late effects of previous irradiation such as post-radiation cancers or sequelae of post-radiation osteoporosis.
Dr. Malgorzata Klimek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic oncology
- cancer biology
- HPV infection
- molecular risk factors
- translational medicine
- cancer staging systems
- radiation therapy
- brachytherapy
- radioresistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
